• Series Overview
• Program Content
• Faculty
• Target Audience
• Learning Objectives
• CPE Credit
• Recertification Credit
• Technical Requirements

The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners read and analyze the articles and view the online presentation, they must successfully complete an online assessment to earn recertification credit.

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A – Clostridium difficile Infection Guidelines: This module focuses on guidelines for Clostridium difficile infections.

Module 1B – Infectious Diseases Potpourri: This module focuses on key studies in the treatment of infectious diseases, including bacteremia, endocarditis, and multidrug resistant gram negative infections.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ASHP and ACCP professional development program for BCIDP recertification approved by the BPS.

Monique Bidell, Pharm.D., BCPS
Assistant Professor of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Albany, New York

Kevin W. Garey, Pharm.D., M.S., FASHP*
Professor and Chair
University of Houston
Houston, Texas

Twisha Patel, Pharm.D., BCIDP, BCPS
Clinical Pharmacist Specialist, Antimicrobial Stewardship/Infectious Diseases
Michigan Medicine
Ann Arbor, Michigan

Jason Schafer, Pharm.D., M.P.H., AAHIVP, BCPS*
Associate Professor, Department of Pharmacy Practice
Jefferson College of Pharmacy, Thomas Jefferson University
Philadelphia, Pennsylvania

Kayla Stover, Pharm.D., BCIDP, BCPS-AQ ID, FCCP, FIDSA
Associate Professor
University of Mississippi School of Pharmacy
Jackson, Mississippi

* Content Matter Experts

The Infectious Diseases Pharmacy Specialty Recertification Literature Study is designed to help board-certified pharmacy practitioners who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS) Board Certification.

Module 1A: Clostridium difficile Infection Guidelines

• Describe the updated Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) clinical practice guidelines for Clostridium difficile infection in adults and children.
• Make recommendations for the management of Clostridium difficile infection in adults and children.

Module 1B: Infectious Diseases Potpourri

• Explain the rationale, methodology, findings, limitations, and implications of the study comparing algorithm-based therapy with usual care for staphylococcal bacteremia.
• Formulate recommendations for the treatment of staphylococcal bacteremia in adults.
• Explain the rationale, methodology, findings, limitations, and implications of the Partial Oral Treatment of Endocarditis (POET) study.
• Formulate recommendations for the route of administration of antibiotic therapy for adults with infective endocarditis.
• Explain the rationale, methodology, findings, limitations, and implications of the study of follow-up blood cultures in patients with bacteremia.
• Formulate recommendations for the use of follow-up blood cultures in patients with bacteremia.
• Explain the rationale, methodology, findings, limitations, and implications of the review of daptomycin use to treat bacteremia caused by vancomycin-resistant Enterococci (VRE).
• Formulate recommendations for the use of daptomycin to treat patients with bacteremia caused by vancomycin-resistant Enterococci (VRE).
• Explain the rationale, methodology, findings, limitations, and implications of the study comparing piperacillin-tazobactam with meropenem for the treatment of bloodstream infection caused by Escherichia coli or Klebsiella pneumoniae that is not susceptible to ceftriaxone.
• Formulate recommendations for antibiotic therapy for patients with bloodstream infection caused by Escherichia coli or Klebsiella pneumoniae that is not susceptible to ceftriaxone.
• Explain the rationale, methodology, findings, limitations, and implications of the study comparing colistin alone with colistin plus meropenem for the treatment of severe infections caused by Gram-negative bacteria not susceptible to carbapenems.
• Formulate recommendations for the treatment of infections caused by carbapenem-resistant Gram-negative bacteria in adults.
• Explain the rationale, methodology, findings, limitations, and implications of the study comparing 14 days with 7 days of antibiotic treatment for uncomplicated gram-negative bacteremia.
• Formulate recommendations for antibiotic treatment for uncomplicated gram-negative bacteremia in hospitalized patients.

The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by April 24, 2022.

Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by October 22, 2019. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Requires an Internet browser and Adobe Reader.